Revision history of "Modification of the production process of a modern group of medicines used to treat chronic obstructive pulmonary disease (COPD)" (Q78523)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 October 2024

  • curprev 05:5305:53, 13 October 2024DG Regio talk contribs 91,840 bytes +6 Changed label, description and/or aliases in pt
  • curprev 05:5305:53, 13 October 2024DG Regio talk contribs 91,834 bytes +32 Set a claim value: summary (P836): O objetivo do projeto é desenvolver dois medicamentos genéricos inalados do grupo LAMA/LABA e LAMA com processo de fabrico modificado, que serão utilizados no tratamento da doença pulmonar obstrutiva crónica (DPOC). Devem conter as seguintes substâncias activas: glicopirrónio e glicopirrónio com indacaterol. Os medicamentos terão uma vantagem sobre as soluções terapêuticas existentes para a DPOC, incluindo a redução da frequência de administração, b...

7 March 2024

12 January 2024

11 June 2023

24 May 2023

2 March 2023

  • curprev 22:2222:22, 2 March 2023DG Regio talk contribs 89,027 bytes −11 Changed label, description and/or aliases in lv, it, da, sk, lt, hu, ro, pt, fr, sv, fi, ga, es, el, de, sl, et, bg, hr, cs, mt, and other parts

25 October 2022

20 October 2022

25 July 2022

  • curprev 20:4720:47, 25 July 2022DG Regio talk contribs 87,379 bytes +56,145 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

19 January 2022

15 January 2022

16 December 2021

7 December 2021

30 November 2021

  • curprev 16:1516:15, 30 November 2021DG Regio talk contribs 18,500 bytes +3,034 Created claim: summary (P836): L’objectif du projet est de mettre au point deux médicaments génériques inhalés du groupe LAMA/LABA et LAMA avec un procédé de fabrication modifié, qui seront utilisés dans le traitement de la maladie pulmonaire obstructive chronique (BPCO). Ils contiendront les substances actives suivantes: glycopyrronium et glycopyrronium avec indacatéro. Les produits auront un avantage par rapport aux solutions existantes dans le domaine du traitement de la M...
  • curprev 16:1516:15, 30 November 2021DG Regio talk contribs 15,466 bytes +221 Changed label, description and/or aliases in fr: translated_label

29 October 2020

14 October 2020

  • curprev 12:5112:51, 14 October 2020DG Regio talk contribs 15,685 bytes +188 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 12:5112:51, 14 October 2020DG Regio talk contribs 15,497 bytes −202 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 12:5112:51, 14 October 2020DG Regio talk contribs 15,699 bytes +2,843 Created claim: summary (P836): The aim of the project is to develop two generic inhaled drugs from the LAMA/LABA and LAMA group with modified manufacturing process, which will be used in the treatment of chronic obstructive pulmonary disease (COPD). They shall contain the following active substances: glycopyrronium and glycopyrronium with indacaterol. The products will have an advantage over the existing COPD therapy solutions, including reducing the frequency of administrati...
  • curprev 12:5112:51, 14 October 2020DG Regio talk contribs 12,856 bytes −2,367 Removed claim: summary (P836): The purpose of the project is to develop two generic sophisticated drugs from LAA/Laba and LAMA about the modified manufacturing process that will be used in the treatment of chronic obstructive pulmonary disease (COPD).They shall contain the following active substances:glycopyoonium and glycopyterol.Products will have an advantage over the existing POP treatment solutions, including a reduction of the frequency of administration, as well as a...

25 September 2020

23 September 2020

17 July 2020

9 June 2020

6 June 2020

26 March 2020

4 March 2020

  • curprev 09:2209:22, 4 March 2020DG Regio talk contribs 13,505 bytes +2,367 Created claim: summary (P836): The purpose of the project is to develop two generic sophisticated drugs from LAA/Laba and LAMA about the modified manufacturing process that will be used in the treatment of chronic obstructive pulmonary disease (COPD).They shall contain the following active substances:glycopyoonium and glycopyterol.Products will have an advantage over the existing POP treatment solutions, including a reduction of the frequency of administration, as well as a n...

18 February 2020

8 February 2020

31 January 2020

13 January 2020